{"id":14552,"date":"2012-09-12T16:16:44","date_gmt":"2012-09-12T14:16:44","guid":{"rendered":"http:\/\/www.myza.co.za\/09\/update-1-s-africas-aspen-boosts-fy-profit-asian-unit-robust\/"},"modified":"2012-09-12T16:16:44","modified_gmt":"2012-09-12T14:16:44","slug":"update-1-s-africas-aspen-boosts-fy-profit-asian-unit-robust","status":"publish","type":"post","link":"https:\/\/www.myza.co.za\/press\/update-1-s-africas-aspen-boosts-fy-profit-asian-unit-robust\/","title":{"rendered":"UPDATE 1-S.Africa&#8217;s Aspen boosts FY profit, Asian unit robust"},"content":{"rendered":"<p>\t\t<span><\/span><\/p>\n<p>* Normalised headline EPS at 636.2 cents vs 523.3 cents<span><\/span><\/p>\n<p><span><\/span><\/p>\n<p>* Sales up 23 percent at 15.3 billion rand<\/p>\n<p><span><\/span><\/p>\n<p>* Asia-Pacific unit doubles sales<\/p>\n<p> (Adds details, share price)<\/p>\n<p><span><\/span><\/p>\n<p>JOHANNESBURG, Sept 12 (Reuters) &#8211; Africa&#8217;s biggest generic<br \/>\ndrugs maker Aspen Pharmacare  booked a 22 percent rise<br \/>\nin full-year profit, helped by a robust showing in its<br \/>\nAsia-Pacific unit.<\/p>\n<p><span><\/span><\/p>\n<p>Aspen, 19 percent owned by Britain GlaxoSmithKline,<br \/>\nsaid in financial results released on Wednesday its normalised<br \/>\ndiluted headline earnings per share totalled 636.2 cents in the<br \/>\nyear to end-June compared with 523.3 cents a year earlier.<\/p>\n<p><span><\/span><\/p>\n<p>Headline EPS, the primary profit gauge in South Africa,<br \/>\nstrips out certain one-off items.<\/p>\n<p><span><\/span><\/p>\n<p>The biggest generic drugs maker in the southern hemisphere,<br \/>\nAspen is one of the companies most likely to benefit as some of<br \/>\nbest-selling name-brand drugs worth more than $100 billion lose<br \/>\npatent protection over the next three years.<\/p>\n<p><span><\/span><\/p>\n<p>Sales increased 23 percent to 15.3 billion rand ($1.88<br \/>\nbillion) with its Asia-Pacific unit doubling its revenue to 6<br \/>\nbillion rand thanks to an acquisition.<\/p>\n<p><span><\/span><\/p>\n<p>Durban-based Aspen completed the acquisition of the generic<br \/>\nbusiness of Australia&#8217;s Sigma Pharmaceuticals last<br \/>\nyear, boosting its presence in the region.<\/p>\n<p><span><\/span><\/p>\n<p>The company said it is looking to expand further in<br \/>\nfast-growing Latin America, where it has small operations in<br \/>\nBrazil, Venezuela and Mexico.<\/p>\n<p><span><\/span><\/p>\n<p>Shares in Aspen, which are up about 44 percent so far this<br \/>\nyear, were down 1.16 percent at 139.36 rand, in line with its<br \/>\nclosest domestic rival Adcock Ingram, which was down<br \/>\n1.35 percent at 59 rand.<br \/>\n($1 = 8.1362 South African rand)<\/p>\n<p> (Reporting by Tiisetso Motsoeneng; Editing by Jon Herskovitz)<\/p>\n<p><span><\/span><\/p>\n<p class=\"copyright\">\n<p>         \t\t\u00a9 Thomson Reuters 2012 All rights reserved<\/p>\n","protected":false},"excerpt":{"rendered":"<p>* Normalised headline EPS at 636.2 cents vs 523.3 cents * Sales up 23 percent at 15.3 billion rand * Asia-Pacific unit doubles sales (Adds details, share price) JOHANNESBURG, Sept 12 (Reuters) &#8211; Africa&#8217;s biggest generic drugs maker Aspen Pharmacare booked a 22 percent rise in full-year profit, helped by a robust showing in its [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","ngg_post_thumbnail":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[830,2370,183],"class_list":{"0":"post-14552","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-south-africa","7":"tag-news","8":"tag-reuters","9":"tag-south-africa-2","10":"entry"},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/posts\/14552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/comments?post=14552"}],"version-history":[{"count":0,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/posts\/14552\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/media?parent=14552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/categories?post=14552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.myza.co.za\/press\/wp-json\/wp\/v2\/tags?post=14552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}